KULKARNI SAMARTH (Chief Executive Officer) sold 40.1% of their position (90K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $5.17M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/22/2026ACC: 0001193125-26-019733
DirectorOfficer· Chief Executive Officer
Since Sep 2018
-90K
Net shares
Net seller
$5.17M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
90K disposed
Non-Derivative Transactions3
Common Shares
Direct
Shares
−21.43K
Price / share
$51.61
Trade value
$1.11M
% of position
9.6%
1/20/2026
224.20K→202.77K
Common Shares
Direct
Shares
−8.57K
Price / share
$52.10
Trade value
$446.34K
% of position
4.2%
1/20/2026
202.77K→194.20K
Common Shares
Direct
Shares
−60K
Price / share
$60.23
Trade value
$3.61M
% of position
30.9%
1/22/2026
194.20K→134.20K
Total
Net shares
−90K
Net value
-$5.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/20/2026 | S · Sale | −21.43K | $51.61 | $1.11M | 9.6% | 224.20K | 202.77K |
| Common Shares Direct | 1/20/2026 | S · Sale | −8.57K | $52.10 | $446.34K | 4.2% | 202.77K | 194.20K |
| Common Shares Direct | 1/22/2026 | S · Sale | −60K | $60.23 | $3.61M | 30.9% | 194.20K | 134.20K |
| Total | −90K | -$5.17M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Shares
IndirectShares owned85.62K
Total
85.62K indirect85.62K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 85.62K | Indirect |
| Total | 85.62K | 85.62K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported